Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vicplas InternationalSGX:569 Gross Margin % is 51.55% as of Jan. 2026, which is 4% below its 10-year median of 53.75. The stock has 5 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Vicplas International ranks better than 50.62% on this metric.
SGX:569's Gross Margin % is ranked better than 50.62% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.115
vs SGX:569: 52.51
Vicplas International had a gross margin of 51.55% for the quarter that ended in Jan. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Vicplas International was -0.80% per year.
Vicplas International (SGX:569) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Vicplas International had a gross margin of 51.55% for the quarter that ended in Jan. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Vicplas International Gross Margin % Related Terms
Vicplas International Gross Margin % Historical Data
* Premium members only.
The historical data trend for Vicplas International's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:569 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Vicplas International's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vicplas International Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Vicplas International's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Vicplas International (SGX:569) has a Gross Margin % of 51.55% as of Jan. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Vicplas International and its competitors. This is near median its historical median of 53.75. Over the past decade, Vicplas International's Gross Margin % has ranged from 51.19 to 58.03. According to the industry distribution chart, Vicplas International ranks #398 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 49.4%.
Is Vicplas International's Gross Margin % too high?
Vicplas International's current Gross Margin % of 51.55% is near median its 10-year median of 53.75. Over the past 10 years, this metric has ranged from a low of 51.19 to a high of 58.03. The Medical Devices & Instruments industry median Gross Margin % is 52.12. Vicplas International's value of 51.55% is 1.1% below this industry median. Based on the distribution chart, Vicplas International ranks #398 out of 806 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Vicplas International's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vicplas International ranks #398 out of 806 companies for Gross Margin %. This puts Vicplas International in the upper half of its industry. The industry median Gross Margin % is 52.12. Vicplas International's value of 51.55% is 1.1% below this benchmark. Historically, Vicplas International's own Gross Margin % has ranged from 51.19 to 58.03 over the past decade. While the company's 10-year median is 53.75 vs. the industry median of 52.12, Vicplas International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vicplas International's current Gross Margin % of 51.55% is 1.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Vicplas International and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vicplas International's current Gross Margin % is 51.55%, which is near median its own 10-year median of 53.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicplas International stock overvalued right now?
Based on GuruFocus' analysis, Vicplas International (SGX:569) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.11, compared to a current price of S$0.08 — trading 30% below its estimated fair value. The current Gross Margin % is 51.55%, which is near median its 10-year median of 53.75 and 1.1% below the Medical Devices & Instruments industry median of 52.12. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Vicplas International (SGX:569), the current Gross Margin % is 51.55% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, Mexico, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:569 has been successfully added to your 
